Showing posts with label UCHITEC (7100). Show all posts
Showing posts with label UCHITEC (7100). Show all posts

Friday, 30 March 2012

CIMB Research upgrades tech sector to Trading Buy

KUALA LUMPUR (March 30): CIMB Equities Research is upgrading the tech sector from Underperform to Trading Buy as sentiment is turning positive, helped by a better book-to-bill ratio.

In its outlook report issued on Friday, it said the sector was not an outright Overweight as 1Q12 may be a weak quarter, similar to 4Q11.

“In light of our recent semicon sector upgrade, we now have three Trading Buys(JCY, MPI, and Unisem) and two Neutral calls (Jobstreet and Uchi). We raise our target prices for JCY, MPI and Unisem but lower our target price for Jobstreet and Uchi. Our top picks are Unisem and JCY,” said CIMB Research.



Get your T+10 interest FREE margin trading account NOW. Attractive brokerage for online trading. Contact Mr Ho at +603-5192 0808 or hoxian@sjsec.com.my for more details.

Monday, 16 January 2012

Uchi: Resilient DPS in challenging FY12

Uchi Technologies Bhd (Jan 13, RM1.16)
Maintain buy at RM1.15 with revised target price of RM1.34 (from RM1.55): Uchi is expected to release its 4QFY11 results by end-February, which are likely to fall within our core net profit estimate of RM47.3 million (+2% year-on-year [y-o-y]). Recall that 9MFY11 net profit amounted to RM38.3 million (+12.9% y-o-y) or 81% of our full-year forecast, thereby implying a slightly weaker 4QFY11. This is due to the continued weak consumer sentiment and uncertain global economic environment. Management, however, has guided that FY11 dividend per share (DPS) of 12 sen will likely remain unchanged from FY10, which implies a final DPS of seven sen (implied payout of 95%) after the interim dividend payment of five sen.

Management has guided for a weaker FY12 based on current order flow and judging from the ongoing global economic uncertainty. Consistent with our macro view, however, its management believes that 2HFY12 will be stronger, underpinned by the introduction of new products and a gradual global economic recovery.

Nevertheless, on the whole, its management believes that FY12 revenue is likely to be weaker by 15% in US dollar terms, affected primarily by the weaker demand for its coffee modules. Demand for its biotech equipment remains fairly resilient and is likely to continue to see growth in FY12. (Uchi’s biotech division is estimated to account for 20% of FY11 group revenue). The company is introducing two new products — an encoder and infra-red module — from early 2QFY12, though near-term contribution is unlikely to be meaningful.

Capital expenditure (capex) for FY12 will likely rise to RM35 million from RM12 million for FY11 as Uchi rushes to complete Phase 3 of its plant expansion, next to its current location in Prai, Penang. The plant will be dedicated to R&D and used primarily for reliability testing, cleanroom and offices for customers instead of expansion of new lines. Of more significance, the higher capex in FY12 is unlikely to affect its DPS for FY12 (Uchi’s cash balance remains high at RM143 million or 38 sen per share as at end 3QFY11)

Our earnings forecast is adjusted for the weaker guidance and higher FY12 capex, thereby resulting in a 11% to 14% cut in our FY12/FY13 forecast. We have also trimmed our FY12 DPS forecast to 11 sen from 12 sen (FY13: 12 sen from 13 sen previously). Our target price for Uchi is lowered to RM1.34 (previously RM1.55), based on an unchanged 11 times FY12 earnings per share.

We retain our “buy” rating as our investment thesis for Uchi remains unchanged, hinging on its strong dividend payouts (average of 79% over the past three years), underpinned by its strong free cash flows. The key risk to our recommendation lies in the stock’s low trading liquidity which could increase stock price volatility during a downturn. — Affin IB Research, Jan 13


This article appeared in The Edge Financial Daily, January 16, 2012.




Get your T+10 interest FREE margin trading account NOW. Attractive brokerage for online trading. Contact Mr Ho at +603-5192 0808 or hoxian@sjsec.com.my for more details.

Friday, 9 December 2011

Semiconductors weak with a challenging outlook

Semiconductor sector
Downgrade to underweight: We downgrade the semiconductor sector from “neutral” to “underweight” due to the de-rating catalysts of no imminent recovery in demand, more interest in defensive sectors and a more challenging outlook. We lower our target price for Unisem (M) Bhd but raise our target price for JobStreet.com. Our top pick is JCY International Bhd.

Despite the deteriorating external environment, the 3Q11 results season saw improvement as there were two outperformers and only two underperformers this time around. This contrasted with the 2Q11 results season when there were three underachievers and no outperformer.

Once again, semiconductor stocks provided the main source of disappointment, with faltering demand the culprit this time around. Utilisation rates did not materially improve in 3Q11 and semiconductor players had difficulty filling up capacity. Unisem plunged into a core loss in 3Q11 from a small profit in 2Q11 as it was affected by slowing demand and poor utilisation rates. Malaysian Pacific Industries Bhd was also buffeted by the challenging external environment. It fell into a loss from a small gain the quarter before.

Non-semiconductor stocks were the star in 3Q11 as two of the three stocks beat expectations while Uchi Technologies Bhd met expectations. JCY surpassed expectations due to better gross margins from better operating efficiency and cost control. JobStreet’s results were also strong as volumes remained firm, offsetting margin erosion from investments in headcount and marketing. — CIMB Research, Dec 8


This article appeared in The Edge Financial Daily, December 9, 2011.




Get your T+10 interest FREE margin trading account NOW. Attractive brokerage for online trading. Contact Mr Ho at +603-5192 0808 or hoxian@sjsec.com.my for more details.
Related Posts Plugin for WordPress, Blogger...